Integrating the ATS/ERS 2019 standards into clinical trials can be a daunting task. However, adopting the guidance leads to more accurate lung function data which helps sponsors gain more robust insight into treatment effects to better prioritize pipelines by focusing on only safe and effective drug candidates.
Join industry experts for the upcoming webinar, “ATS/ERS 2019 Standards – Integrating the Guidance into Your Trial” on March 3rd at 10 am PT/1 pm ET, and learn how to implement these new guidelines. We’ll present:
- A look at the guidance by phase (with examples)
- What are the challenges in implementing the new guidance? What are the benefits?
- How is clinical trial spirometry different from in-clinic spirometry?
- Audience Q&A
Kevin McCarthy, RPFT
Director, Respiratory Solutions at ERT, and member of the ATS/ERS 2019 Spirometry Update Task Force
Sandra B Weibel, MD
Assistant Professor of Medicine at Thomas Jefferson University; Medical Director of Respiratory Care and Pulmonary Function Laboratory
Dawn Patterson, RRT, CPFT
Director, Respiratory Solutions at ERT